3rd Quarter - Report

AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 3187 Food and Drug Administration Safety and Innovation Act; H.R. 5651 Food and Drug Administration Reform Act of 2012

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
TRACY SPICER —
AMY TEJRAL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5651 (112th), S. 3187 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.